Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON
  1. Accueil Zonebourse
  2. Actions
  3. Chine
  4. Shanghai Stock Exchange
  5. WuXi AppTec Co., Ltd.
  6. Actualités
  7. Autres langues
    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Rapport
Cours en clôture. Cours en clôture Shanghai Stock Exchange - 19/10
145 CNY   +0.90%
2018Hong Kong parti pour être en tête du classement des IPO en 2018
RE
2018Fosun Tourism (Club Med) lève 428 millions de dollars lors de son IPO à Hong Kong
RE
SynthèseGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
SynthèseToute l'actualitéAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur WUXI APPTEC CO., LTD.
18/10WUXI APPTEC : ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services f..
06/10SIRONA BIOCHEM : On Advancement of TFC-1067 Compound
06/10SIRONA BIOCHEM CORP. : Sirona Biochem gibt Fortschritte bei seinem Wirkstoff TFC-1067 beka..
22/09DMD : Charting the Path for New Therapeutics and Better Care
25/08WUXI APPTEC : Investor Day - Industry Trend and Company Strategy
25/08WUXI APPTEC : Investor Day - Financial Performance
25/08WUXI APPTEC : Investor Day - WuXi Biology
25/08WUXI APPTEC : Investor Day - WuXi Chemistry
25/08WUXI APPTEC : Investor Day - WuXi Testing
13/08WUXI APPTEC : H1 Profit Surges 56% on Strong Revenue
12/08WuXi AppTec Co., Ltd. Announces Earnings Results for the Half Year Ended June 30, 2021
12/08WUXI APPTEC : Reports Strong 2021 Interim Results
03/08WUXI APPTEC : STA Completes Acquisition of Bristol Myers Squibb Manufacturing Facility in ..
26/07WUXI APPTEC : Inside information - proposed disposal of a shares by a shareholder
16/07WUXI APPTEC : Expects Up To 55% Growth in H1 Profit
15/07WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2021
13/07Temasek's Net Portfolio Rose to US$283 Billion for Fiscal Year Ended March
06/07UPDATE/MÄRKTE ASIEN/Richtungswechsel in Sydney nach RBA-Beschlüssen
06/07Chinese Pharma Stocks Drop on Proposed New Rules for Oncology Drug Trials
06/07China stocks end lower as healthcare, tech firms tumble
06/07China stocks fall on healthcare slump; Hong Kong down
16/06China stocks fall as Sino-West tensions hit risk appetite
03/06China's Stemirna raises about $200 million to fund COVID-19 vaccine development
28/05Megarobo Technology Co., Ltd. announced that it has received $65 million in funding fro..
26/05Engine Biosciences Pte. Ltd. announced that it has received SGD 57 million in funding f..
14/05WUXI APPTEC : Articles of association
14/05WUXI APPTEC : (1) poll results of the 2020 annual general meeting, the first a share class..
14/05WuXi AppTec Co., Ltd. Approves the 2020 Profit Distribution Plan
07/05WUXI APPTEC : Unlocking and trading of the initial grant of restricted a shares for the se..
07/05Certain A Shares of WuXi AppTec Co., Ltd. are subject to a Lock-Up Agreement Ending on ..
30/04WuXi AppTec to Seek Acquisitions
30/04WUXI APPTEC : Profit Soars 395% in First Quarter on Robust Demand for Pharmaceutical Resea..
29/04WuXi AppTec First-Quarter Net Profit Jumped as Investment Income Increased
29/04Wuxi Apptec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 20..
29/04WUXI APPTEC : End of lock-up period of restricted a shares under the a share ipo
29/04WuXi AppTec Co., Ltd. Provides Revenue Guidance for the Second Half of 2021
28/04WUXI APPTEC : Fulfillment of vesting conditions for first vesting period of first tranche ..
28/04WUXI APPTEC : Cancellation of part of the share options granted under the 2019 a share inc..
28/04WUXI APPTEC : Unlocking and trading of the reserved grant of restricted a shares under the..
23/04China's Wuxi City Hosts Healthcare Conference Amid Efforts to Boost Biomedical Sector
20/04WuXi AppTec Co., Ltd. Proposes the 2020 Profit Distribution Plan
08/04WUXI APPTEC : Form of proxy for the first H Share class meeting
08/04WUXI APPTEC : Notice of the first H Share class meeting for 2021
08/04WUXI APPTEC : Form of proxy for the Annual General Meeting
08/04WUXI APPTEC : Notice of Annual General Meeting of 2020
08/04WUXI APPTEC : 2020 AGM Circular
30/03Wuxi Apptec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 202..
30/03WUXI APPTEC : (1) proposed further increase of registered capital of the company; (2) prop..
30/03WuXi AppTec Co., Ltd. Announces Change of Members of Board Committees
30/03WuXi AppTec Co., Ltd. Proposes Profit Distribution Plan for the Year Ended December 31,..
29/03INNOVEL announced that it has received $30.56 million in funding from WuXi AppTec Co., ..
19/03WUXI APPTEC : to List Nearly 63 Million Shares in Shanghai as Lockup Ends
18/03WUXI APPTEC : End of lock-up period of a shares with restricted conditions issued under th..
09/03WUXI APPTEC : Partners Set Up $15 Million Private Equity Fund; Hong Kong Shares Rise 3%
08/03WUXI APPTEC : Connected transaction - participation in the establishment of the joint vent..
05/03WUXI APPTEC : Announcement on preliminary financial data for the year ended december 31, 2..
04/03WUXI APPTEC : Next Day Disclosure Return
03/03WUXI APPTEC : acquire OXGENE
01/03WUXI APPTEC : Unlocking and trading of the restricted a shares granted under the special g..
10/02Contract Research Organization (CRO) Market Hit $ 68,198.3 Mn in 2025 & to grow with a ..
21/01WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021
11/01WUXI APPTEC : Atlantic Healthcare to attend WuXi Global Forum, January 11-13th 2021
2020WUXI APPTEC : Closes BuyBack and Cancellation of A Shares
2020PRESS RELEASE : ViGeneron and WuXi Advanced Therapies enter Strategic Manufacturing Partne..
2020WUXI APPTEC : Invests $21 Million in Biotech Startup; Shares Slide
2020WUXI APPTEC : Third-Quarter Net Profit Fell on Higher Costs
2020WuXi AppTec Co., Ltd. Announces Impairment Losses for the Third Quarter Ended September..
2020Wuxi Apptec Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30..
2020WuXi AppTec Co., Ltd. acquired Milestone Pharma.
2020Wuxi Apptec Co., Ltd. announced that it expects to receive CNY 6.4572 billion in fundin..
2020WuXi AppTec (Hong Kong) Limited announced that it expects to receive CNY 4.09392 billio..
2020WUXI APPTEC : Next Day Disclosure Return
2020WUXI APPTEC : Exercise of share options granted under the reserved grant of the 2018 a sha..
2020WUXI APPTEC : Inside information proposed disposal of a shares by a shareholder
2020SIRONA BIOCHEM : Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
1  2  3Suiv.
Prochain événement sur WUXI APPTEC CO., LTD.